Xolair and Acute myocardial infarction - a phase IV clinical study of FDA data

Summary:

Acute myocardial infarction is reported as a side effect among people who take Xolair (omalizumab), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Ventolin, and have Urticaria.

The phase IV clinical study analyzes which people have Acute myocardial infarction when taking Xolair. It is created by eHealthMe based on reports of 77,224 people who have side effects when taking Xolair from the FDA, and is updated regularly.

What is Xolair?

Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,554 Xolair users. Check the latest studies of Xolair.

What is Acute myocardial infarction?

Acute myocardial infarction (acute heart attack) is found to be associated with 1,461 drugs and 1,618 conditions by eHealthMe. Check the latest studies of Acute myocardial infarction.

On Jul, 11, 2026

77,224 people reported to have side effects when taking Xolair.
Among them, 75 people (0.1%) have Acute myocardial infarction.

Could Xolair cause Acute myocardial infarction?

Among these 75 people:

How long have people been on Xolair when they have Acute myocardial infarction? *

What is the gender of people who have Acute myocardial infarction when taking Xolair? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Acute myocardial infarction when taking Xolair? *

What are other drugs people take besides Xolair? *

What are other side effects people have besides Acute myocardial infarction? *

Dyspnea (difficult or laboured breathing): 18 people, 24.00%
Cough: 17 people, 22.67%
Nausea And Vomiting: 14 people, 18.67%
Muscle Aches (muscle pain): 14 people, 18.67%
Itching: 13 people, 17.33%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 13 people, 17.33%
Joint Pain: 13 people, 17.33%
Paleness (unusual lightness of skin colour): 13 people, 17.33%
Productive Cough: 13 people, 17.33%
Fatigue (feeling of tiredness): 13 people, 17.33%

What are the existing conditions these people have? *

Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 4.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 2.67%
High Blood Pressure: 2 people, 2.67%
Allergic Rhinitis: 2 people, 2.67%
Renal Cell Carcinoma (a kidney cancer): 1 person, 1.33%
Quit Smoking: 1 person, 1.33%
Percutaneous Coronary Intervention: 1 person, 1.33%
Multiple Allergies (allergy to multiple agents): 1 person, 1.33%
Itching: 1 person, 1.33%
High Blood Cholesterol: 1 person, 1.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xolair and have Acute myocardial infarction?

- Check whether Acute myocardial infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xolair:

Xolair (77,554 reports)

Browse all side effects of Xolair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute myocardial infarction:

Acute myocardial infarction (1,461 drugs)

Browse all the conditions that are associated with Acute myocardial infarction:

Acute myocardial infarction (1,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omalizumab (the active ingredients of Xolair) and Xolair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.